Skin melanomas showed a higher frequency of specific gene alterations such as CDKN2A deletion (P < .05), BRAF single-nucleotide variants (SNVs; P < .01), and TERT promoter variants (P < .01) than mucosal melanomas. This evidence concerns the gene BRAF and cutaneous melanoma.